Ostrow S S
Am J Med Sci. 1983 Jan-Feb;285(1):24-37. doi: 10.1097/00000441-198301000-00003.
Carcinoma of the testes is the fourth leading cause of death in males between the ages of 15-54, and its incidence may be increasing. Nonseminomatous testicular cancer represents 50% of all testicular tumors. There have been recent advances in diagnosis, staging and therapy of these tumors. Currently, there is a high success rate with platinum containing combination chemotherapy regimens in patients with advanced stages of disease. The article reviews the evolution of successful chemotherapy and the issues of adjuvant therapy for early stage disease, radiation therapy and the role of retroperitoneal lymphadenectomy and surgery following chemotherapy.
睾丸癌是15至54岁男性中第四大主要死因，其发病率可能正在上升。非精原细胞瘤性睾丸癌占所有睾丸肿瘤的50%。这些肿瘤在诊断、分期和治疗方面最近都有进展。目前，含铂联合化疗方案在晚期疾病患者中成功率很高。本文回顾了成功化疗的演变以及早期疾病辅助治疗、放射治疗以及化疗后腹膜后淋巴结清扫术和手术的作用等问题。
